Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients

2 years ago 58
NCI has helped launch the Pragmatica-Lung Study, a phase 3 randomized clinical trial of a two-drug combination to treat patients with advanced non-small cell lung cancer. The simplified trial design aims to increase accessibility for participants.
Read Entire Article